CWC27 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.728800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.536000E-01
Normal-vs-Stage2
9.960200E-01
Normal-vs-Stage3
2.448400E-01
Normal-vs-Stage4
3.395400E-01
Stage1-vs-Stage2
3.320200E-01
Stage1-vs-Stage3
4.405500E-02
Stage1-vs-Stage4
5.247400E-01
Stage2-vs-Stage3
2.526400E-01
Stage2-vs-Stage4
4.651400E-01
Stage3-vs-Stage4
4.730100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.330200E-01
Normal-vs-AfricanAmerican
7.922800E-01
Normal-vs-Asian
2.782600E-01
Caucasian-vs-AfricanAmerican
7.079000E-01
Caucasian-vs-Asian
7.883700E-02
AfricanAmerican-vs-Asian
2.617400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.407400E-01
Normal-vs-Female
9.625600E-01
Male-vs-Female
6.260800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.646600E-01
Normal-vs-Age(41-60Yrs)
8.647000E-01
Normal-vs-Age(61-80Yrs)
9.695600E-01
Normal-vs-Age(81-100Yrs)
6.992000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.920000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.960800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.130000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.146000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.003600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.053200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.314400E-01
Normal-vs-Daily Drinker
7.476000E-01
Normal-vs-Weekly Drinker
9.777600E-01
Normal-vs-Occasional Drinker
4.440000E-01
Normal-vs-Social Drinker
8.104200E-01
Non Drinker-vs-Daily Drinker
3.970600E-01
Non Drinker-vs-Weekly Drinker
5.035600E-01
Non Drinker-vs-Occasional Drinker
7.398100E-03
Non Drinker-vs-Social Drinker
2.267800E-01
Daily Drinker-vs-Weekly Drinker
7.353600E-01
Daily Drinker-vs-Occasional Drinker
3.122000E-02
Daily Drinker-vs-Social Drinker
7.544800E-01
Weekly Drinker-vs-Occasional Drinker
4.114000E-01
Weekly Drinker-vs-Social Drinker
8.346000E-01
Occasional Drinker-vs-Social Drinker
5.262300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.384400E-01
Normal-vs-Grade 2
5.652600E-01
Normal-vs-Grade 3
1.937250E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.246800E-01
Grade 1-vs-Grade 3
2.985900E-02
Grade 1-vs-Grade 4
2.384400E-01
Grade 2-vs-Grade 3
5.532500E-02
Grade 2-vs-Grade 4
5.652600E-01
Grade 3-vs-Grade 4
1.937250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.931000E-01
Normal-vs-NonDiabetic
8.468600E-01
Diabetic-vs-NonDiabetic
2.095000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.709600E-01
Normal-vs-NoPancreatitis
9.495200E-01
Pancreatitis-vs-NoPancreatitis
4.680200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.960800E-01
Normal-vs-N1
9.998800E-01
N0-vs-N1
6.364400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.862400E-01
Normal-vs-TP53-NonMutant
7.517000E-01
TP53-Mutant-vs-TP53-NonMutant
5.979600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
